Covestor’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54K Sell
110
-40
-27% -$21.7K 0.04% 672
2025
Q4
$87K Sell
150
-85
-36% -$48.1K 0.05% 649
2025
Q3
$114K Buy
235
+38
+19% +$17.7K 0.06% 507
2025
Q2
$80K Buy
197
+6
+3% +$2.51K 0.05% 678
2025
Q1
$95K Buy
191
+35
+22% +$19K 0.06% 528
2024
Q4
$81K Buy
156
+4
+3% +$2.2K 0.05% 644
2024
Q3
$94K Buy
152
+1
+0.7% +$592 0.06% 558
2024
Q2
$84K Sell
151
-1
-0.7% -$573 0.05% 601
2024
Q1
$89K Buy
152
+8
+6% +$4.49K 0.06% 617
2023
Q4
$76K Sell
144
-9
-6% -$4.36K 0.05% 662
2023
Q3
$78K Sell
153
-4
-3% -$2.13K 0.06% 567
2023
Q2
$82K Sell
157
-18
-10% -$9.71K 0.06% 556
2023
Q1
$101K Buy
175
+1
+0.6% +$564 0.09% 366
2022
Q4
$96K Sell
174
-5
-3% -$2.65K 0.08% 408
2022
Q3
$91K Sell
179
-58
-24% -$32.5K 0.08% 400
2022
Q2
$129K Sell
237
-84
-26% -$46.2K 0.1% 271
2022
Q1
$190K Buy
321
+121
+61% +$69.5K 0.13% 170
2021
Q4
$134K Buy
+200
New +$125K 0.19% 73

Other funds holding TMO

Covestor's TMO Position: Q1 2026 in Review

Covestor reduced its Thermo Fisher Scientific (TMO) stake by 27% in Q1 2026, selling an estimated $21.7K and leaving 110 shares worth $54K. The position accounts for 0.04% of the portfolio, ranked #672.

Covestor first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $190K in Q1 2022. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Covestor held 110 shares of Thermo Fisher Scientific worth $54K as of Q1 2026.
  • Covestor sold 40 Thermo Fisher Scientific shares in Q1 2026, an estimated $21.7K.
  • Thermo Fisher Scientific made up 0.04% of Covestor's portfolio in Q1 2026, its #672 holding.
  • Covestor first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Thermo Fisher Scientific position peaked at $190K in Q1 2022.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.